The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com

PARTNER NEWS:

Tue, Apr 22, 2:45 PM, Zacks
Sarepta Soars on Eteplirsen Submission Plans - Analyst Blog
Sarepta shares soared over 39% after the company announced it would submit a NDA for eteplirsen by year end.

Tue, Apr 22, 9:49 AM, Zacks
Keep an Eye on these 3 Biotech Stocks - Earnings ESP
This sell-off was more due to a change in sentiment rather than a shift in industry fundamentals.

FREE registration required to continue...

You have viewed 6 pages within the last 6 hours. To continue, please register at The Online Investor for unlimited page views and our free weekly newsletter, by entering your name and email address below. Registration is absolutely free. By registering, you agree to the terms of our privacy policy, disclaimer, & terms of service.

Problems with your registration ''sticking?'' Enable your browser to receive our ''cookie'' to resolve. Other questions? Email us at: info@theonlineinvestor.com

Biogen Idec Inc (BIIB) Page | The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.